Title of article :
IL-10-conditioned dendritic cells prevent autoimmune diabetes in NOD and humanized HLA-DQ8/RIP-B7.1 mice
Author/Authors :
Tai، نويسنده , , Ningwen and Yasuda، نويسنده , , Hisafumi and Xiang، نويسنده , , Yufei and Zhang، نويسنده , , Li and Rodriguez-Pinto، نويسنده , , Daniel and Yokono، نويسنده , , Koichi and Sherwin، نويسنده , , Robert and Wong، نويسنده , , F. Susan and Nagata، نويسنده , , Masao and Wen، نويسنده , , Li، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2011
Pages :
14
From page :
336
To page :
349
Abstract :
This study was to determine whether BMDCs cultured in the presence of IL-10 (G/10-DCs) could promote T cell tolerance and prevent autoimmune diabetes in two different animal models of T1D. Our results showed that G/10-DCs suppressed both insulitis and spontaneous diabetes in NOD and HLA-DQ8/RIP-B7.1 mice. The suppression was likely to be mediated by T cells, as we found that regulatory CD4+CD25+Foxp3+ cells were significantly increased in G/10-DC treated animals. In vivo, the G/10-DCs inhibited diabetogenic T cell proliferation; in vitro, they had reduced expression of costimulatory molecules and produced little IL-12/23 p40 or IL-6 but a large amount of IL-10 when compared with DCs matured in the presence of IL-4 (G/4-DC). We conclude that IL-10-treated DCs are tolerogenic and induce islet-directed immune tolerance, which was likely to be mediated by T regulatory cells. This non-antigen-specific DC-based approach offers potential for a new therapeutic intervention in T1D.
Keywords :
DC therapy , IL-10 , Autoimmune diabetes , HLA transgenic mouse , NOD
Journal title :
Clinical Immunology
Serial Year :
2011
Journal title :
Clinical Immunology
Record number :
1855107
Link To Document :
بازگشت